FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 358:1974-1975 May 1, 2008 Number 18 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear

(In-Formation.) By João Biehl. 466 pp., illustrated. Princeton, NJ, Princeton University Press, 2007. $29.95. ISBN 978-0-691-13008-8.

Since 1996, the Brazilian AIDS Control Program (BACP) has provided free access to highly active antiretroviral therapy (HAART) for all symptomatic patients and for asymptomatic people who have fewer than 200 CD4+ cells per cubic millimeter. HAART is also considered for patients with between 200 and 350 CD4+ cells per cubic millimeter. The decision as to whether to start treatment is based on individual cases. During 2006, approximately 180,000 persons in Brazil received treatment; the mortality rate dropped from 9.6 per 100,000 persons in 1996 to 5.1 per 100,000 persons in 2006. The program is a model for controlling AIDS . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.